Roche Launches Hostile Bid for Genentech (TheStreet.com)

The Swiss drugmaker intends to launch a tender offer for the 44.2% of Genentech it doesn’t already own at $86.50 a share, a lower price than the $89 a share offer it made in July.

More: continued here

This entry was posted on Friday, January 30th, 2009 at 5:01 am and is filed under Stock-Picks. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.